← back to search

Whijae Roh

Pfizer (United States) · US
Area of research
Pulmonary and Respiratory Medicine · Molecular Biology
Research interest
Research interests include RNA modifications and cancer, Ferroptosis and cancer prognosis, Cancer Genomics and Diagnostics, and Lung Cancer Treatments and Mutations.
h-index
15
citations
4,871
works
117
NIH funding
primary concept
Medicine
email

Recent publications

<i>CXCL9:SPP1</i> macrophage polarity identifies a network of cellular programs that control human cancers
Science 2023cited by 584position: middledoi
Glasdegib plus intensive or non-intensive chemotherapy for untreated acute myeloid leukemia: results from the randomized, phase 3 BRIGHT AML 1019 trial
Leukemia 2023cited by 26position: middledoi
High-Resolution Profiling of Lung Adenocarcinoma Identifies Expression Subtypes with Specific Biomarkers and Clinically Relevant Vulnerabilities
Cancer Research 2022cited by 36position: firstdoi
Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade
Nature Medicine 2021cited by 405position: middledoi
The Lipogenic Regulator SREBP2 Induces Transferrin in Circulating Melanoma Cells and Suppresses Ferroptosis
Cancer Discovery 2020cited by 225position: middledoi
Multiomics profiling of primary lung cancers and distant metastases reveals immunosuppression as a common characteristic of tumor cells with metastatic plasticity
Genome biology 2020cited by 63position: middledoi
Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade
Research Square 2020cited by 11position: middledoi
Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade
Cancer Discovery 2016cited by 1,006position: middledoi
Clonal evolution in breast cancer revealed by single nucleus genome sequencing
Nature 2014cited by 1,102position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Benjamin Tomlinson · University of Alabama at Birmingham1 papers (2023–2023)Hongui Cha · Cancer Research UK1 papers (2022–2022)Jianxiang Wang · Zhejiang University1 papers (2023–2023)Tadeusz Robak · Medical University of Lodz1 papers (2023–2023)Mendy Miller · Massachusetts Institute of Technology1 papers (2022–2022)Franziska Michor · Harvard University1 papers (2014–2014)Ken Chen · Teikyo University1 papers (2014–2014)Xueli Liu · Shandong University of Technology1 papers (2023–2023)Geoffrey Chan · Roswell Park Comprehensive Cancer Center1 papers (2023–2023) · 1 papers (2014–2014)Wendy Ma · Roswell Park Comprehensive Cancer Center1 papers (2023–2023)Erin Jou · Northwell Health1 papers (2023–2023)Hervé Dombret · University of London Institute in Paris1 papers (2023–2023)Gad Getz · Broad Institute1 papers (2022–2022)Yifat Geffen · Broad Institute1 papers (2022–2022)Pau Montesinos · Hospital Universitari i Politècnic La Fe1 papers (2023–2023)Xiuqing Shi · Chinese Academy of Medical Sciences & Peking Union Medical College1 papers (2014–2014)Hong Zhang · The University of Texas Southwestern Medical Center1 papers (2014–2014)Selina Vattathil · University of California, Davis1 papers (2014–2014)Jörge E. Cortes · Cecil College1 papers (2023–2023)